This highlights the potential of the rd9 mouse model as a tool to study early phases of retinal degeneration in a slow-progressing phenotype, with the aim of searching for disease biomarkers (e.g., BRB alterations or opsin mislocalization (Chang et al., 2002; Thompson et al., 2012). Here, PITPNM1 is linked to retinal degeneration.